Analyst Recommendations

BMO Capital analyst issues MARKET PERFORM recommendation for ATUSF on January 28, 2026 04:04PM ET. The previous analyst recommendation was Market Perform.ATUSF was trading at $34.429 at issue...

January 28, 2026   ATUSF 1.30%

BMO Capital analyst issues OUTPERFORM recommendation for CNL on January 28, 2026 04:06PM ET. The previous analyst recommendation was Outperform.CNL was trading at $19.145 at issue of the...

January 28, 2026   CNL 3.58%

BMO Capital analyst issues OUTPERFORM recommendation for MAUTF on January 28, 2026 04:07PM ET. The previous analyst recommendation was Outperform.MAUTF was trading at $10.184 at issue of the...

January 28, 2026   MAUTF 6.07%

BMO Capital analyst issues OUTPERFORM recommendation for MDALF on January 28, 2026 04:07PM ET. The previous analyst recommendation was Outperform.MDALF was trading at $29.5582 at issue of the...

January 28, 2026   MAUTF 6.07%

BMO Capital analyst issues OUTPERFORM recommendation for MTRAF on January 28, 2026 04:09PM ET. The previous analyst recommendation was Outperform.MTRAF was trading at $68.73 at issue of the...

January 28, 2026   MTRAF 1.85%

BMO Capital analyst issues OUTPERFORM recommendation for SLI on January 28, 2026 04:08PM ET. The previous analyst recommendation was Outperform.SLI was trading at $5.3182 at issue of the...

January 28, 2026   SLI 1.17%

RBC Capital analyst issues OUTPERFORM recommendation for AGFMF on January 28, 2026 04:13PM ET. The previous analyst recommendation was Outperform.AGFMF was trading at $13.53 at issue of the...

January 28, 2026   AGFMF 1.54%

H.C. Wainwright analyst issues BUY recommendation for ITRG on January 28, 2026 04:45PM ET. The previous analyst recommendation was Buy.ITRG was trading at $4.43 at issue of the...

January 28, 2026   ITRG 5.13%

RBC Capital analyst issues OUTPERFORM recommendation for IVZ on January 28, 2026 03:05PM ET. The previous analyst recommendation was Outperform.IVZ was trading at $27.79 at issue of the...

January 28, 2026   IVZ 0.12%

RBC Capital analyst issues OUTPERFORM recommendation for HCA on January 28, 2026 03:06PM ET. The previous analyst recommendation was Outperform.HCA was trading at $486.14999 at issue of the...

January 28, 2026   HCA 0.37%